Udder Health Market - Global Forecast to 2029
| 出版年月 | 2024年7月 |
| ページ数 | 291 |
| 図表数 | 360 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%.
世界の乳房健康市場は、5.9%のCAGRで2024年の12億米ドルから2029年までに16億米ドルに達すると予測されています。
The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2020 and May 2024. Players in the global udder health market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.
“The Devices segment accounted the second-largest market share in the udder health market.”
In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.
“Dairy farms segment of the udder health market is expected to witness the fastest CAGR.”
By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment’s rapid growth.
“The Dairy cattle segment of the udder health market accounted for the largest market share.”
Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment’s dominance reflects the industry’s emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.
“Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR.”
By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there’s a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment’s rapid growth in the udder health industry.
“North America to have the second largest market share in the udder health market during the forecast period.”
North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.
A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–25%, and Tier 3–40%
- By Designation: C-level–45%, Director Level–25%, and Others–30%
- By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%
A breakdown of the primary participants (demand side) for the udder health market refer to for the report is provided below:
- By Veterinary Care Setting Type: Dairy Farms-65%, Veterinary Hospitals and Clinics-35%
- By Designation: Farm Owners-55%, Veterinarians-45%
- By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%
Key Market Players:
The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).
Research Coverage:
The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market’s top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
Analysis of key Drivers: Drivers (Increasing Demand of Milk and Dairy Products, Increasing number of veterinary practitioner in developed economies, Increasing Incidence of Mastitis and Other Udder Health Disorders, Technological Advancements in Udder Health Monitoring), Restrains (Lack of Awareness and Education Among Small-Scale Dairy Farmers), Opportunities (Gradual transitions of small and medium-scale dairy farms from manual milking to mechanized milking solutions, Increasing per capita income of farmers in developing countries), Challenges (Regulatory control on livestock industry to reduce outbreak of diseases) influencing the growth of the udder health market.
- Market Penetration: Comprehensive information on the product portfolios of the leading companies in the udder health market. The report breaks down the market by product type, veterinary care setting types, animal types, disease types and region.
- Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the udder health market.
- Market Development: Comprehensive data on attractive rising markets broken down by product category, veterinary care setting types, animal types, disease types and region.
- Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the udder health market.
- Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS 27
1.2.2 MARKET SCOPE 28
1.2.3 YEARS CONSIDERED 29
1.2.4 CURRENCY CONSIDERED 29
1.3 STAKEHOLDERS 30
1.4 RECESSION IMPACT 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.2 RESEARCH METHODOLOGY DESIGN 32
2.2.1 SECONDARY DATA 32
2.2.1.1 Key data from secondary sources 33
2.2.2 PRIMARY DATA 33
2.2.2.1 Key data from primary sources 34
2.2.2.2 Key industry insights 35
2.3 MARKET SIZE ESTIMATION 37
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 42
2.5 MARKET SHARE ESTIMATION 43
2.6 STUDY ASSUMPTIONS 43
2.7 RESEARCH LIMITATIONS 44
2.7.1 METHODOLOGY-RELATED LIMITATIONS 44
2.7.2 SCOPE-RELATED LIMITATIONS 44
2.8 RISK ASSESSMENT 44
2.9 RECESSION IMPACT ANALYSIS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 50
4.1 UDDER HEALTH MARKET OVERVIEW 50
4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023) 51
4.3 UDDER HEALTH MARKET: REGIONAL MIX 52
4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing demand for milk & dairy products 54
5.2.1.2 Rising incidence of mastitis 55
5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures 55
5.2.1.4 Technological advancements in udder health monitoring devices 57
5.2.2 RESTRAINTS 58
5.2.2.1 Limited resources and low awareness among small-scale dairy farmers 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Gradual transition from manual milking to mechanized milking solutions 58
5.2.3.2 Increasing per capita income of farmers in emerging markets 59
5.2.4 CHALLENGES 60
5.2.4.1 Stringent regulatory guidelines for livestock industry 60
5.3 INDUSTRY TRENDS 60
5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS 60
5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS 61
5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES 61
5.4 VALUE CHAIN ANALYSIS 61
5.5 TECHNOLOGY ANALYSIS 62
5.5.1 KEY TECHNOLOGIES 62
5.5.1.1 Telemedicine 62
5.5.1.2 AI integration in udder health 63
5.5.2 COMPLEMENTARY TECHNOLOGIES 63
5.5.2.1 Nutritional supplements 63
5.5.2.2 Integration of barn environmental management system 64
5.5.3 ADJACENT TECHNOLOGIES 64
5.5.3.1 Precision livestock farming 64
5.5.3.2 Integration of cattle & livestock management software 65
5.6 PORTER’S FIVE FORCES ANALYSIS 66
5.6.1 THREAT OF NEW ENTRANTS 67
5.6.2 BARGAINING POWER OF SUPPLIERS 67
5.6.3 BARGAINING POWER OF BUYERS 68
5.6.4 THREAT OF SUBSTITUTES 68
5.6.5 COMPETITIVE RIVALRY 68
5.7 REGULATORY LANDSCAPE 69
5.7.1 REGULATORY ANALYSIS 69
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.8 PATENT ANALYSIS 74
5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET 74
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 75
5.9 TRADE ANALYSIS 77
5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS 77
5.10 PRICING ANALYSIS 78
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE 78
5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION 78
5.11 REIMBURSEMENT ANALYSIS 79
5.12 KEY CONFERENCES AND EVENTS (2024−2025) 80
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 80
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
5.13.2 BUYING CRITERIA 81
5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET 82
5.15 ECOSYSTEM ANALYSIS 82
5.16 CASE STUDY ANALYSIS 85
5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY 85
5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY 85
5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS 86
5.17 SUPPLY CHAIN ANALYSIS 86
5.18 ADJACENT MARKETS 88
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
5.20 INVESTMENT & FUNDING SCENARIO 89
6 UDDER HEALTH MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
6.2 DEVICES 91
6.2.1 MILK QUALITY ANALYZERS 93
6.2.1.1 Ability to ensure quality & safety to drive market 93
6.2.2 MILK SAMPLING EQUIPMENT 94
6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market 94
6.2.3 MILK MANAGEMENT SYSTEMS 96
6.2.3.1 Rising technological advancements to support market growth 96
6.2.4 OTHER UDDER HEALTH DEVICES 97
6.3 PHARMACEUTICALS 99
6.3.1 ANTIBIOTICS 100
6.3.1.1 Advancements in formulations and delivery methods to propel market 100
6.3.2 VACCINES 102
6.3.2.1 Growth in dairy farm sector to boost demand 102
6.3.3 ANTI-INFLAMMATORY DRUGS 103
6.3.3.1 Innovative product launches to support market growth 103
6.3.4 INTRAMAMMARY INFUSIONS 105
6.3.4.1 Ability to provide targeted treatment during dry season to drive market 105
6.3.5 TEAT SEALANTS 106
6.3.5.1 Antimicrobial properties to drive market 106
6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS 108
6.4 SUPPLEMENTS 109
6.4.1 VITAMINS & MINERALS 110
6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake 110
6.4.2 PROBIOTICS & PREBIOTICS 111
6.4.2.1 Growing demand for nutraceuticals to drive market 111
6.4.3 OTHER UDDER HEALTH SUPPLEMENTS 112
7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING 114
7.1 INTRODUCTION 115
7.2 DAIRY FARMS 115
7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET 115
7.3 VETERINARY HOSPITALS AND CLINICS 116
7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH 116
8 UDDER HEALTH MARKET, BY ANIMAL TYPE 118
8.1 INTRODUCTION 119
8.2 DAIRY CATTLE 120
8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET 120
8.3 OTHER ANIMAL TYPES 121
9 UDDER HEALTH MARKET, BY DISEASE TYPE 123
9.1 INTRODUCTION 124
9.2 CLINICAL MASTITIS 125
9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET 125
9.3 OTHER DISEASE TYPES 126
10 UDDER HEALTH MARKET, BY REGION 129
10.1 INTRODUCTION 130
10.2 NORTH AMERICA 130
10.2.1 NORTH AMERICA: RECESSION IMPACT 131
10.2.2 US 134
10.2.2.1 Increasing number of veterinary practitioners to drive market 134
10.2.3 CANADA 137
10.2.3.1 High R&D investments for udder monitoring products to drive market 137
10.3 EUROPE 140
10.3.1 EUROPE: RECESSION IMPACT 141
10.3.2 GERMANY 145
10.3.2.1 Advanced dairy farming practices to fuel uptake 145
10.3.3 UK 148
10.3.3.1 High adoption of advanced veterinary technologies to propel market 148
10.3.4 FRANCE 151
10.3.4.1 Expanding dairy industry to support market growth 151
10.3.5 ITALY 154
10.3.5.1 Growing investments in udder health solutions to drive market 154
10.3.6 SWITZERLAND 157
10.3.6.1 Growing demand for mastitis detectors to fuel uptake 157
10.3.7 SPAIN 160
10.3.7.1 Increasing establishment of dairy farms to boost demand 160
10.3.8 REST OF EUROPE 163
10.4 ASIA PACIFIC 166
10.4.1 ASIA PACIFIC: RECESSION IMPACT 167
10.4.2 JAPAN 172
10.4.2.1 Growing focus on automated milking systems to boost demand 172
10.4.3 CHINA 175
10.4.3.1 Increase in milk consumption to propel market 175
10.4.4 INDIA 178
10.4.4.1 Growing population of dairy cattle to drive market 178
10.4.5 AUSTRALIA 181
10.4.5.1 Stringent dairy farming regulations to propel market 181
10.4.6 SOUTH KOREA 184
10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market 184
10.4.7 REST OF ASIA PACIFIC 187
10.5 LATIN AMERICA 190
10.5.1 LATIN AMERICA: RECESSION IMPACT 190
10.5.2 BRAZIL 194
10.5.2.1 Emphasis on improving milk quality to boost demand 194
10.5.3 MEXICO 197
10.5.3.1 Improvements in animal welfare standards to support market growth 197
10.5.4 REST OF LATIN AMERICA 200
10.6 MIDDLE EAST & AFRICA 203
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 203
10.6.2 GCC COUNTRIES 207
10.6.2.1 Improvements in economic stability to support market growth 207
10.6.3 REST OF MIDDLE EAST & AFRICA 209
11 COMPETITIVE LANDSCAPE 213
11.1 OVERVIEW 213
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET 214
11.3 REVENUE ANALYSIS 214
11.4 MARKET SHARE ANALYSIS 215
11.4.1 RANKING OF KEY MARKET PLAYERS 217
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 217
11.5.1 STARS 217
11.5.2 EMERGING LEADERS 217
11.5.3 PERVASIVE PLAYERS 218
11.5.4 PARTICIPANTS 218
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 219
11.5.5.1 Company footprint 219
11.5.5.2 Region footprint 220
11.5.5.3 Product footprint 221
11.5.5.4 Veterinary care setting footprint 222
11.5.5.5 Animal type footprint 223
11.5.5.6 Disease type footprint 224
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 225
11.6.1 PROGRESSIVE COMPANIES 225
11.6.2 RESPONSIVE COMPANIES 225
11.6.3 DYNAMIC COMPANIES 225
11.6.4 STARTING BLOCKS 226
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 227
11.7 COMPANY VALUATION AND FINANCIAL METRICS 228
11.7.1 FINANCIAL METRICS 228
11.7.2 COMPANY VALUATION 228
11.8 R&D EXPENDITURE OF KEY PLAYERS 229
11.9 BRAND/PRODUCT COMPARISON 229
11.10 COMPETITIVE SCENARIO 230
11.10.1 PRODUCT LAUNCHES & APPROVALS 230
11.10.2 DEALS 231
11.10.3 EXPANSIONS 231
11.10.4 OTHER DEVELOPMENTS 232
12 COMPANY PROFILES 233
12.1 KEY PLAYERS 233
12.1.1 VETOQUINOL S.A. 233
12.1.1.1 Business overview 233
12.1.1.2 Products offered 234
12.1.1.3 Recent developments 235
12.1.1.3.1 Deals 235
12.1.1.3.2 Other developments 235
12.1.1.4 MnM view 235
12.1.1.4.1 Key strengths 235
12.1.1.4.2 Strategic choices 235
12.1.1.4.3 Weaknesses & competitive threats 236
12.1.2 ZOETIS INC. 237
12.1.2.1 Business overview 237
12.1.2.2 Products offered 238
12.1.2.3 Recent developments 239
12.1.2.3.1 Product launches 239
12.1.2.3.2 Expansions 239
12.1.2.4 MnM view 239
12.1.2.4.1 Key strengths 239
12.1.2.4.2 Strategic choices 239
12.1.2.4.3 Weaknesses & competitive threats 240
12.1.3 MERCK & CO., INC. 241
12.1.3.1 Business overview 241
12.1.3.2 Products offered 242
12.1.3.3 Recent developments 243
12.1.3.3.1 Product launches & approvals 243
12.1.3.4 MnM view 243
12.1.3.4.1 Key strengths 243
12.1.3.4.2 Strategic choices 243
12.1.3.4.3 Weaknesses & competitive threats 243
12.1.4 VIRBAC 244
12.1.4.1 Business overview 244
12.1.4.2 Products offered 245
12.1.4.3 MnM view 246
12.1.4.3.1 Key strengths 246
12.1.4.3.2 Strategic choices 246
12.1.4.3.3 Weaknesses & competitive threats 246
12.1.5 ECOLAB 247
12.1.5.1 Business overview 247
12.1.5.2 Products offered 248
12.1.5.3 Recent developments 249
12.1.5.3.1 Product launches 249
12.1.5.3.2 Deals 249
12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 250
12.1.6.1 Business overview 250
12.1.6.2 Products offered 251
12.1.6.3 MnM view 252
12.1.6.3.1 Key strengths 252
12.1.6.3.2 Strategic choices 252
12.1.6.3.3 Weaknesses & competitive threats 252
12.1.7 ELANCO ANIMAL HEALTH INCORPORATED 253
12.1.7.1 Business overview 253
12.1.7.2 Products offered 254
12.1.8 DELAVAL 255
12.1.8.1 Business overview 255
12.1.8.2 Products offered 256
12.1.8.3 Recent developments 258
12.1.8.3.1 Product launches 258
12.1.8.3.2 Other developments 258
12.1.9 ORFFA 259
12.1.9.1 Business overview 259
12.1.9.2 Products offered 259
12.1.9.3 Recent developments 259
12.1.9.3.1 Deals 259
12.1.10 AHV INTERNATIONAL B.V. 260
12.1.10.1 Business overview 260
12.1.10.2 Products offered 260
12.1.11 BOUMATIC LLC 261
12.1.11.1 Business overview 261
12.1.11.2 Products offered 261
12.1.12 GEA GROUP AKTIENGESELLSCHAFT 262
12.1.12.1 Business overview 262
12.1.12.2 Products offered 263
12.1.13 G SHEPHERD ANIMAL HEALTH 264
12.1.13.1 Business overview 264
12.1.13.2 Products offered 264
12.1.13.3 Recent developments 265
12.1.13.3.1 Other developments 265
12.1.14 CEVA SANTÉ ANIMALE 266
12.1.14.1 Business overview 266
12.1.14.2 Products offered 266
12.2 OTHER PLAYERS 267
12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW 267
12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW 269
12.2.3 LELY: COMPANY OVERVIEW 271
12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW 273
12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW 275
12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW 276
12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW 277
12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW 278
12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW 278
12.2.10 MASTAPLEX: COMPANY OVERVIEW 279
12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW 279
13 APPENDIX 280
13.1 DISCUSSION GUIDE 280
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287
13.3 CUSTOMIZATION OPTIONS 289
13.4 RELATED REPORTS 289
13.5 AUTHOR DETAILS 290
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 29
TABLE 2 STUDY ASSUMPTION ANALYSIS 43
TABLE 3 UDDER HEALTH MARKET: RISK ASSESSMENT ANALYSIS 44
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 73
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 8 UDDER HEALTH: LIST OF MAJOR PATENTS 76
TABLE 9 IMPORT AND EXPORT DATA FOR UDDER HEALTH PRODUCTS, BY COUNTRY 77
TABLE 10 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY TYPE 78
TABLE 11 AVERAGE SELLING PRICE OF UDDER HEALTH PRODUCTS, BY REGION 78
TABLE 12 UDDER HEALTH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 80
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 81
TABLE 14 KEY BUYING CRITERIA FOR TOP THREE END USERS 81
TABLE 15 UDDER HEALTH MARKET: ROLE IN ECOSYSTEM 83
TABLE 16 CASE STUDY 1: EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY 85
TABLE 17 CASE STUDY 2: AUTOMATION OF PRE-TEAT DIPPING FOR EFFICIENCY 85
TABLE 18 CASE STUDY 3: UTILIZING HERD MANAGEMENT SOFTWARE FOR
DATA-DRIVEN DECISIONS 86
TABLE 19 UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 91
TABLE 20 UDDER HEALTH MARKET FOR DEVICES, BY COUNTRY, 2022–2029 (USD MILLION) 92
TABLE 21 MILK QUALITY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 22 MILK SAMPLING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 95
TABLE 23 MILK MANAGEMENT SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 24 OTHER UDDER HEALTH DEVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 99
TABLE 25 UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY COUNTRY,
2022–2029 (USD MILLION) 100
TABLE 26 ANTIBIOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 27 VACCINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 28 ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 29 INTRAMAMMARY INFUSIONS, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 30 TEAT SEALANTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 31 OTHER UDDER HEALTH PHARMACEUTICALS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 108
TABLE 32 UDDER HEALTH MARKET FOR SUPPLEMENTS, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 33 VITAMINS & MINERALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 34 PROBIOTICS & PREBIOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 112
TABLE 35 OTHER UDDER HEALTH SUPPLEMENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 36 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 115
TABLE 37 UDDER HEALTH MARKET FOR DAIRY FARMS, BY COUNTRY,
2022–2029 (USD MILLION) 116
TABLE 38 UDDER HEALTH MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 39 UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 119
TABLE 40 UDDER HEALTH MARKET FOR DAIRY CATTLE, BY COUNTRY,
2022–2029 (USD MILLION) 121
TABLE 41 UDDER HEALTH MARKET FOR OTHER ANIMAL TYPES, BY COUNTRY,
2022–2029 (USD MILLION) 122
TABLE 42 UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 124
TABLE 43 UDDER HEALTH MARKET FOR CLINICAL MASTITIS, BY COUNTRY,
2022–2029 (USD MILLION) 126
TABLE 44 UDDER HEALTH MARKET FOR OTHER DISEASE TYPES, BY COUNTRY,
2022–2029 (USD MILLION) 128
TABLE 45 UDDER HEALTH MARKET, BY REGION, 2022–2029 (USD MILLION) 130
TABLE 46 NORTH AMERICA: UDDER HEALTH MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 131
TABLE 47 NORTH AMERICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 131
TABLE 48 NORTH AMERICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (THOUSAND UNITS) 132
TABLE 49 NORTH AMERICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 132
TABLE 50 NORTH AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 132
TABLE 51 NORTH AMERICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 133
TABLE 52 NORTH AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 133
TABLE 53 NORTH AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 133
TABLE 54 NORTH AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 134
TABLE 55 US: KEY MACROINDICATORS 135
TABLE 56 US: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 135
TABLE 57 US: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022–2029 (USD MILLION) 135
TABLE 58 US: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 136
TABLE 59 US: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 136
TABLE 60 US: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 136
TABLE 61 US: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 137
TABLE 62 US: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 137
TABLE 63 CANADA: KEY MACROINDICATORS 138
TABLE 64 CANADA: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 138
TABLE 65 CANADA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 138
TABLE 66 CANADA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 139
TABLE 67 CANADA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 139
TABLE 68 CANADA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 139
TABLE 69 CANADA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 140
TABLE 70 CANADA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 140
TABLE 71 EUROPE: UDDER HEALTH MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 72 EUROPE: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 142
TABLE 73 EUROPE: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (THOUSAND UNITS) 143
TABLE 74 EUROPE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 143
TABLE 75 EUROPE: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 76 EUROPE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 144
TABLE 77 EUROPE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 144
TABLE 78 EUROPE: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 144
TABLE 79 EUROPE: UDDER HEALTH MARKET, BY DISEASE TYPE 2022–2029 (USD MILLION) 145
TABLE 80 GERMANY: KEY MACROINDICATORS 145
TABLE 81 GERMANY: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 146
TABLE 82 GERMANY: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 146
TABLE 83 GERMANY: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 2022–2029 (USD MILLION) 146
TABLE 84 GERMANY: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 147
TABLE 85 GERMANY: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 147
TABLE 86 GERMANY: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 147
TABLE 87 GERMANY: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 148
TABLE 88 UK: KEY MACROINDICATORS 149
TABLE 89 UK: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 149
TABLE 90 UK: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 91 UK: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 150
TABLE 92 UK: UDDER HEALTH MARKT FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 150
TABLE 93 UK: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 150
TABLE 94 UK: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 151
TABLE 95 UK: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 151
TABLE 96 FRANCE: KEY MACROINDICATORS 152
TABLE 97 FRANCE: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 152
TABLE 98 FRANCE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 152
TABLE 99 FRANCE: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 153
TABLE 100 FRANCE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 153
TABLE 101 FRANCE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 153
TABLE 102 FRANCE: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 154
TABLE 103 FRANCE: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 154
TABLE 104 ITALY: KEY MACROINDICATORS 155
TABLE 105 ITALY: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 155
TABLE 106 ITALY: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 155
TABLE 107 ITALY: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 156
TABLE 108 ITALY: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 156
TABLE 109 ITALY: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 156
TABLE 110 ITALY: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 157
TABLE 111 ITALY: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 157
TABLE 112 SWITZERLAND: KEY MACROINDICATORS 158
TABLE 113 SWITZERLAND: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 158
TABLE 114 SWITZERLAND: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 158
TABLE 115 SWITZERLAND: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 2022–2029 (USD MILLION) 159
TABLE 116 SWITZERLAND: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 159
TABLE 117 SWITZERLAND: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 159
TABLE 118 SWITZERLAND: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 160
TABLE 119 SWITZERLAND: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 160
TABLE 120 SPAIN: KEY MACROINDICATORS 161
TABLE 121 SPAIN: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 161
TABLE 122 SPAIN: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 161
TABLE 123 SPAIN: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 162
TABLE 124 SPAIN: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 162
TABLE 125 SPAIN: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 162
TABLE 126 SPAIN: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 163
TABLE 127 SPAIN: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 163
TABLE 128 REST OF EUROPE: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 164
TABLE 129 REST OF EUROPE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 164
TABLE 130 REST OF EUROPE: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 131 REST OF EUROPE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 165
TABLE 132 REST OF EUROPE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 165
TABLE 133 REST OF EUROPE: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 166
TABLE 134 REST OF EUROPE: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 166
TABLE 135 ASIA PACIFIC: UDDER HEALTH MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 136 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 169
TABLE 137 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (THOUSAND UNITS) 169
TABLE 138 ASIA PACIFIC: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 170
TABLE 139 ASIA PACIFIC: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION) 170
TABLE 140 ASIA PACIFIC: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 171
TABLE 141 ASIA PACIFIC: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 171
TABLE 142 ASIA PACIFIC: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 171
TABLE 143 ASIA PACIFIC: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 172
TABLE 144 JAPAN: KEY MACROINDICATORS 172
TABLE 145 JAPAN: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 173
TABLE 146 JAPAN: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 173
TABLE 147 JAPAN: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 173
TABLE 148 JAPAN: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 174
TABLE 149 JAPAN: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 174
TABLE 150 JAPAN: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 174
TABLE 151 JAPAN: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 175
TABLE 152 CHINA: KEY MACROINDICATORS 175
TABLE 153 CHINA: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 176
TABLE 154 CHINA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 176
TABLE 155 CHINA: UDDER HEALTH MARKET, BY PHARMACEUTICALS
2022–2029 (USD MILLION) 176
TABLE 156 CHINA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 177
TABLE 157 CHINA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 177
TABLE 158 CHINA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 177
TABLE 159 CHINA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 178
TABLE 160 INDIA: KEY MACROINDICATORS 178
TABLE 161 INDIA: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 179
TABLE 162 INDIA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 179
TABLE 163 INDIA: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 164 INDIA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 180
TABLE 165 INDIA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 180
TABLE 166 INDIA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 180
TABLE 167 INDIA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 181
TABLE 168 AUSTRALIA: KEY MACROINDICATORS 181
TABLE 169 AUSTRALIA: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 182
TABLE 170 AUSTRALIA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 182
TABLE 171 AUSTRALIA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 182
TABLE 172 AUSTRALIA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 183
TABLE 173 AUSTRALIA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 183
TABLE 174 AUSTRALIA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 183
TABLE 175 AUSTRALIA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 184
TABLE 176 SOUTH KOREA: KEY MACROINDICATORS 184
TABLE 177 SOUTH KOREA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 185
TABLE 178 SOUTH KOREA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 185
TABLE 179 SOUTH KOREA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 180 SOUTH KOREA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 186
TABLE 181 SOUTH KOREA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 186
TABLE 182 SOUTH KOREA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 186
TABLE 183 SOUTH KOREA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 187
TABLE 184 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 187
TABLE 185 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 188
TABLE 186 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 187 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 188 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 189
TABLE 189 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 189
TABLE 190 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 190
TABLE 191 LATIN AMERICA: UDDER HEALTH MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 191
TABLE 192 LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 191
TABLE 193 LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (THOUSAND UNIT) 191
TABLE 194 LATIN AMERICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 192
TABLE 195 LATIN AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 196 LATIN AMERICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 193
TABLE 197 LATIN AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 193
TABLE 198 LATIN AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 193
TABLE 199 LATIN AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 194
TABLE 200 BRAZIL: KEY MACROINDICATORS 194
TABLE 201 BRAZIL: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 195
TABLE 202 BRAZIL: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 195
TABLE 203 BRAZIL: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 195
TABLE 204 BRAZIL: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 196
TABLE 205 BRAZIL: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 196
TABLE 206 BRAZIL: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 196
TABLE 207 BRAZIL: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 197
TABLE 208 MEXICO: KEY MACROINDICATORS 197
TABLE 209 MEXICO: UDDER HEALTH MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 198
TABLE 210 MEXICO: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 198
TABLE 211 MEXICO: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2022–2029 (USD MILLION) 198
TABLE 212 MEXICO: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 199
TABLE 213 MEXICO: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 199
TABLE 214 MEXICO: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 199
TABLE 215 MEXICO: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 200
TABLE 216 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 201
TABLE 217 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY DEVICES,
2022–2029 (USD MILLION) 201
TABLE 218 REST OF LATIN AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION)2022–2029 (USD MILLION) 201
TABLE 219 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY TYPE,
2022–2029 (USD MILLION) 202
TABLE 220 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 202
TABLE 221 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 202
TABLE 222 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 203
TABLE 223 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY REGION,
2022–2029 (USD MILLION) 204
TABLE 224 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 204
TABLE 225 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (THOUSAND UNITS) 204
TABLE 226 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 205
TABLE 227 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS,
BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 228 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 229 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 206
TABLE 230 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 206
TABLE 231 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 207
TABLE 232 GCC COUNTRIES: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 207
TABLE 233 GCC COUNTRIES: UDDER HEALTH MARKET FOR DEVICES, BY TYPE,
2022–2029 (USD MILLION) 208
TABLE 234 GCC COUNTRIES: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 235 GCC COUNTRIES: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2022–2029 (USD MILLION) 208
TABLE 236 GCC COUNTRIES: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2022–2029 (USD MILLION) 209
TABLE 237 GCC COUNTRIES: UDDER HEALTH MARKET, BY ANIMAL TYPE,
2022–2029 (USD MILLION) 209
TABLE 238 GCC COUNTRIES: UDDER HEALTH MARKET, BY DISEASE TYPE,
2022–2029 (USD MILLION) 209
TABLE 239 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 210
TABLE 240 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR DEVICES,
BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 241 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 242 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 243 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022–2029 (USD MILLION) 211
TABLE 244 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION) 212
TABLE 245 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022–2029 (USD MILLION) 212
TABLE 246 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS 214
TABLE 247 UDDER HEALTH MARKET: REGION FOOTPRINT 220
TABLE 248 UDDER HEALTH MARKET: PRODUCT FOOTPRINT 221
TABLE 249 UDDER HEALTH MARKET: VETERINARY CARE SETTINGS FOOTPRINT 222
TABLE 250 UDDER HEALTH MARKET: ANIMAL TYPE FOOTPRINT 223
TABLE 251 UDDER HEALTH MARKET: DISEASE TYPE FOOTPRINT 224
TABLE 252 UDDER HEALTH MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 227
TABLE 253 UDDER HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 227
TABLE 254 UDDER HEALTH MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020−MAY 2024 230
TABLE 255 UDDER HEALTH MARKET: DEALS, JANUARY 2020−MAY 2024 231
TABLE 256 UDDER HEALTH MARKET: EXPANSIONS, JANUARY 2020−MAY 2024 231
TABLE 257 UDDER HEALTH MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2024 232
TABLE 258 VETOQUINOL S.A.: COMPANY OVERVIEW 233
TABLE 259 VETOQUINOL S.A.: PRODUCTS OFFERED 234
TABLE 260 VETOQUINOL S.A.: DEALS, JANUARY 2020−MAY 2024 235
TABLE 261 VETOQUINOL S.A.: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2024 235
TABLE 262 ZOETIS INC.: COMPANY OVERVIEW 237
TABLE 263 ZOETIS INC: PRODUCTS OFFERED 238
TABLE 264 ZOETIS INC.: PRODUCT LAUNCHES, JANUARY 2020−MAY 2024 239
TABLE 265 ZOETIS INC.: EXPANSIONS, JANUARY 2020−MAY 2024 239
TABLE 266 MERCK & CO., INC.: COMPANY OVERVIEW 241
TABLE 267 MERCK & CO., INC.: PRODUCTS OFFERED 242
TABLE 268 MERCK & CO., INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2020−MAY 2024 243
TABLE 269 VIRBAC: COMPANY OVERVIEW 244
TABLE 270 VIRBAC: PRODUCTS OFFERED 245
TABLE 271 ECOLAB: COMPANY OVERVIEW 247
TABLE 272 ECOLAB: PRODUCTS OFFERED 248
TABLE 273 ECOLAB: PRODUCT LAUNCHES, JANUARY 2020−MAY 2024 249
TABLE 274 ECOLAB: DEALS, JANUARY 2020−MAY 2024 249
TABLE 275 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW 250
TABLE 276 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED 251
TABLE 277 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW 253
TABLE 278 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED 254
TABLE 279 DELAVAL: COMPANY OVERVIEW 255
TABLE 280 DALAVAL: PRODUCTS OFFERED 256
TABLE 281 DELAVAL: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 258
TABLE 282 DELAVAL: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2024 258
TABLE 283 ORFFA: COMPANY OVERVIEW 259
TABLE 284 ORFFA: PRODUCTS OFFERED 259
TABLE 285 ORFFA: DEALS, JANUARY 2020−MAY 2024 259
TABLE 286 AHV INTERNATIONAL B.V.: COMPANY OVERVIEW 260
TABLE 287 AHV INTERNATIONAL B.V.: PRODUCTS OFFERED 260
TABLE 288 BOUMATIC LLC: COMPANY OVERVIEW 261
TABLE 289 BOUMATIC LLC: PRODUCTS OFFERED 261
TABLE 290 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW 262
TABLE 291 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED 263
TABLE 292 G SHEPHERD ANIMAL HEALTH: COMPANY OVERVIEW 264
TABLE 293 G SHEPHERD ANIMAL HEALTH: PRODUCTS OFFERED 264
TABLE 294 G SHEPHERD ANIMAL HEALTH: OTHER DEVELOPMENTS,
JANUARY 2020–MAY 2024 265
TABLE 295 CEVA SANTÉ ANIMALE: COMPANY OVERVIEW 266
LIST OF FIGURES
FIGURE 1 UDDER HEALTH MARKET SEGMENTATION 28
FIGURE 2 UDDER HEALTH MARKET: REGIONS COVERED 28
FIGURE 3 RESEARCH DESIGN 31
FIGURE 4 PRIMARY SOURCES 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 35
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY VETERINARY CARE SETTING, DESIGNATION, AND REGION 36
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION OF ZOETIS INC. 38
FIGURE 10 SUPPLY-SIDE ANALYSIS: UDDER HEALTH MARKET (2023) 39
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 40
FIGURE 12 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 41
FIGURE 13 TOP-DOWN APPROACH 41
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY 42
FIGURE 15 UDDER HEALTH MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 45
FIGURE 16 UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION) 46
FIGURE 17 UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE,
2024 VS. 2029 (USD MILLION) 46
FIGURE 18 UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE,
2024 VS. 2029 (USD MILLION) 47
FIGURE 19 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING,
2024 VS. 2029 (USD MILLION) 47
FIGURE 20 UDDER HEALTH MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 21 UDDER HEALTH MARKET, BY DISEASE TYPE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 22 GEOGRAPHIC SNAPSHOT OF UDDER HEALTH MARKET 49
FIGURE 23 INCREASING INCIDENCE OF MASTITIS AND GROWING FOCUS ON PREVENTIVE CARE TO DRIVE MARKET 50
FIGURE 24 PHARMACEUTICALS SEGMENT ACCOUNTED FOR LARGEST
MARKET SHARE IN 2023 51
FIGURE 25 ASIA PACIFIC SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 52
FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 52
FIGURE 27 UDDER HEALTH MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 53
FIGURE 28 PRODUCTION OF MILK AND MILK PRODUCTS BY REGION (IN THOUSAND TONNES−MILK EQUIVALENT) 54
FIGURE 29 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER (2019−2023) 56
FIGURE 30 NUMBER OF VETERINARIANS IN TOP FIVE EUROPEAN COUNTRIES (2023) 57
FIGURE 31 UDDER HEALTH MARKET: VALUE CHAIN ANALYSIS 62
FIGURE 32 UDDER HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 66
FIGURE 33 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 71
FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013–DECEMBER 2023) 74
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR UDDER HEALTH PATENTS (JANUARY 2013–DECEMBER 2023) 75
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR UDDER HEALTH PATENTS
(JANUARY 2013–DECEMBER 2023) 76
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 80
FIGURE 38 KEY BUYING CRITERIA FOR END USERS 81
FIGURE 39 ECOSYSTEM MARKET/MAP 83
FIGURE 40 UDDER HEALTH MARKET: ROLE IN ECOSYSTEM 84
FIGURE 41 UDDER HEALTH MARKET: SUPPLY CHAIN ANALYSIS 87
FIGURE 42 ADJACENT MARKETS FOR UDDER HEALTH MARKET 88
FIGURE 43 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
FIGURE 44 INVESTMENT/VENTURE CAPITAL SCENARIO IN UDDER HEALTH MARKET,
2019–2023 89
FIGURE 45 EUROPE: UDDER HEALTH MARKET SNAPSHOT 141
FIGURE 46 ASIA PACIFIC: UDDER HEALTH MARKET SNAPSHOT 168
FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN UDDER HEALTH MARKET (2019−2023) 215
FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN UDDER HEALTH MARKET (2023) 215
FIGURE 49 RANKING OF KEY PLAYERS IN UDDER HEALTH MARKET, 2023 217
FIGURE 50 UDDER HEALTH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 218
FIGURE 51 UDDER HEALTH MARKET: COMPANY FOOTPRINT 219
FIGURE 52 UDDER HEALTH MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 226
FIGURE 53 EV/EBITDA OF KEY VENDORS L 228
FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 228
FIGURE 55 R&D EXPENDITURE OF KEY PLAYERS IN UDDER HEALTH MARKET, 2021−2023 229
FIGURE 56 BRAND/PRODUCT COMPARISON ANALYSIS 229
FIGURE 57 VETOQUINOL S.A.: COMPANY SNAPSHOT (2023) 234
FIGURE 58 ZOETIS INC.: COMPANY SNAPSHOT (2023) 238
FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2023) 242
FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2023) 245
FIGURE 61 ECOLAB: COMPANY SNAPSHOT (2023) 248
FIGURE 62 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023) 251
FIGURE 63 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2023) 254
FIGURE 64 DELAVAL: COMPANY SNAPSHOT (2023) 256
FIGURE 65 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT (2023) 263
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11